Rennova Health (NSDQ:RNVA) said today that it plans to spin off its advanced molecular services division into an independent, publicly-traded company. The spin-off is slated to take place at the end of September.
Rennova’s board has also cleared the spin-off of its health technology solutions arm in a similar deal, according to the company.
Get the full story at our sister site, Drug Delivery Business News.
The post Rennova to spin off advanced molecular services biz appeared first on MassDevice.